BSE Live
Dec 12, 16:01Prev. Close
67.10
Open Price
67.66
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:58Prev. Close
66.56
Open Price
67.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Valiant Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||
| SHAREHOLDER'S FUNDS | ||||
| Equity Share Capital | 43.45 | 43.45 | 32.56 | |
| Total Share Capital | 43.45 | 43.45 | 32.56 | |
| Reserves and Surplus | 190.86 | 193.41 | 67.93 | |
| Total Reserves and Surplus | 190.86 | 193.41 | 67.93 | |
| Total Shareholders Funds | 234.31 | 236.86 | 100.49 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||
| Long Term Borrowings | 104.35 | 74.66 | 59.40 | |
| Deferred Tax Liabilities [Net] | 1.24 | 0.62 | 0.67 | |
| Other Long Term Liabilities | 1.21 | 1.39 | 1.60 | |
| Long Term Provisions | 0.13 | 0.08 | 0.08 | |
| Total Non-Current Liabilities | 106.93 | 76.75 | 61.75 | |
| CURRENT LIABILITIES | ||||
| Short Term Borrowings | 16.86 | 1.39 | 0.00 | |
| Trade Payables | 40.72 | 25.93 | 47.30 | |
| Other Current Liabilities | 1.84 | 1.65 | 3.31 | |
| Short Term Provisions | 0.20 | 0.12 | 0.12 | |
| Total Current Liabilities | 59.62 | 29.08 | 50.73 | |
| Total Capital And Liabilities | 400.86 | 342.69 | 212.97 | |
| ASSETS | ||||
| NON-CURRENT ASSETS | ||||
| Tangible Assets | 48.33 | 50.05 | 48.12 | |
| Intangible Assets | 0.11 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 155.78 | 42.65 | 0.68 | |
| Fixed Assets | 204.22 | 92.70 | 48.80 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 4.02 | 24.44 | 13.59 | |
| Total Non-Current Assets | 208.24 | 117.14 | 62.39 | |
| CURRENT ASSETS | ||||
| Current Investments | 0.00 | 37.61 | 34.02 | |
| Inventories | 3.99 | 10.02 | 13.04 | |
| Trade Receivables | 72.12 | 45.73 | 88.57 | |
| Cash And Cash Equivalents | 75.99 | 106.21 | 1.34 | |
| Short Term Loans And Advances | 0.06 | 0.03 | 0.07 | |
| OtherCurrentAssets | 40.45 | 25.95 | 13.54 | |
| Total Current Assets | 192.62 | 225.54 | 150.58 | |
| Total Assets | 400.86 | 342.69 | 212.97 | |
| OTHER ADDITIONAL INFORMATION | ||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||
| Contingent Liabilities | 76.08 | 16.73 | 0.42 | |
| BONUS DETAILS | ||||
| Bonus Equity Share Capital | 16.28 | 16.28 | 16.28 | |
| NON-CURRENT INVESTMENTS | ||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 |
19.11.2025
Valiant Lab Consolidated September 2025 Net Sales at Rs 46.20 crore, up 115.1% Y-o-Y
12.11.2025
Valiant Lab Standalone September 2025 Net Sales at Rs 45.99 crore, up 114.11% Y-o-Y
22.08.2025
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y
22.05.2025
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y
19.11.2025
Valiant Lab Consolidated September 2025 Net Sales at Rs 46.20 crore, up 115.1% Y-o-Y
12.11.2025
Valiant Lab Standalone September 2025 Net Sales at Rs 45.99 crore, up 114.11% Y-o-Y
22.08.2025
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y
22.05.2025
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y